Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Dantonello, Tobias M.; Vokuhl, Christian; Scheer, Monika et al.
Paratesticular alveolar rhabdomyosarcomas do not harbor typical translocations: a distinct entity with favorable prognosis?VIRCHOWS ARCHIV. Bd. 472. H. 3. 2018 S. 441-449
Kreipe, H; Schmidt, M
Pathologie, Prognose und PrädiktionColloquium Senologie 2018/2019. München: Agileum Verlagsgesellschaft mbH 2018
Cook, N. S.; Balp, M.; Chatterjee, S. et al.
PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH) REPORT POSITIVE EXPERIENCE AFTER PARTICIPATING IN AN ONLINE QUANTITATIVE PREFERENCE SURVEYVALUE IN HEALTH. Bd. 21. 2018 S. S148-S149
Moehler, M.; Maderer, A.; Lordick, F. et al.
Perioperative chemotherapy plus /- EGFR inhibition in unselected patients with locally advanced esophagogastric cancer: a randomized phase II study with a large advanced biomarker program of the German Cancer Society (AIO/CAO STO-0801)ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 69-69
Huber, Y.; Pfirrmann, D.; Gebhardt, I. et al.
Persistent improvement of liver function tests and health-related quality of life from an individualized exercise program in patients with histological confirmed NAFLD - the HELP studyJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S580-S580
Mobus, V.; Mahlberg, R.; Janni, W. et al.
Pharmacokinetic results of a subcutaneous injection of trastuzumab into the thigh versus into the abdominal wall in patients with HER2-positive primary breast cancer (BC) treated within the neo-/adjuvant GAIN-2 studyCANCER RESEARCH. Bd. 78. H. 4. 2018
Stoessel, S.; Neu, M. A.; Wingerter, A. et al.
Phase Angle from Bioelectrical Impedance is Reduced and Related to Muscle Strength in Children and Adolescents with CancerPEDIATRIC BLOOD & CANCER. Bd. 65. 2018 S. S545-S546
Hillemanns, P.; Sehouli, J.; Harter, P. et al.
Phase III Randomized Controlled Study to Evaluate the Impact of Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer - AGO Desktop III / ENGOT OV20ONCOLOGY RESEARCH AND TREATMENT. Bd. 41. 2018 S. 11-11
Bang, Y. -J.; Ruiz, E. Yanez; Van Cutsem, E. et al.
Phase III, randomised trial of avelumab versus physician's choice of chemotherapy as third-line treatment of patients with advanced gastric or gastro-oesophageal junction cancer: primary analysis of JAVELIN Gastric 300ANNALS OF ONCOLOGY. Bd. 29. H. 10. 2018 S. 2052-2060
Vogel, Arndt; Kasper, Stefan; Bitzer, Michael et al.
PICCA study: panitumumab in combination with cisplatin/gemcitabine chemotherapy in KRAS wild-type patients with biliary cancer-a randomised biomarker-driven clinical phase II AIO studyEUROPEAN JOURNAL OF CANCER. Bd. 92. 2018 S. 11-19